The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock

被引:23
作者
Altavilla, D
Squadrito, F
Campo, GM
Squadrito, G
Arlotta, M
Urna, G
Sardella, A
Quartarone, C
Saitta, A
Caputi, AP
机构
[1] Univ Messina, Sch Med, Inst Pharmacol, I-98122 Messina, Italy
[2] Univ Messina, Sch Med, Dept Internal Med, I-98122 Messina, Italy
[3] Univ Messina, Sch Biol Sci, Chair Pharmacol, I-98122 Messina, Italy
关键词
lazaroids; endotoxin shock; nitric oxide (NO) synthase; inducible;
D O I
10.1016/S0014-2999(99)00051-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of our study was to investigate the effect of the 21-aminosteroid U-74389G [21-< 4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl-pregna-1,4,9,(11) triene-3,20-dione( z)-2-butenedionate] on the I-arginine-nitric oxide (NO) pathway in a rat model of endotoxin shock. Endotoxin shock was produced in male rats by a single intravenous (i.v.) injection of 20 mg/kg of Salmonella Enteritidis lipopolysaccharide (LPS). Rats were treated with U-74389G (7.5, 15 and 30 mg/kg i.v.) or vehicle (1 ml/kg i.v.)5 min after endotoxin challenge. Lipopolysaccharide administration reduced survival rate (0%, 72 h after endotoxin administration) decreased mean arterial blood pressure, enhanced plasma concentration of bilirubin and alanine aminotransferase and increased plasma nitrite concentrations. Lipopolysaccharide injection also increased the activity of inducible NO synthase in the liver and in the aorta. Furthermore aortic rings from shocked rats showed a marked hyporeactivity to phenylephrine (1 nM-10 mu M). In addition lipopolysaccharide (50 mu g/ml for 4 h) in vitro stimulation significantly increased nitrite production in peritoneal macrophages harvested from normal rats. Treatment with U-74389G (15 and 30 mg/kg i.v., 5 min after endotoxin challenge) significantly protected against lipopolysaccharide-induced lethality (90% survival rate 24 h and 80% 72 h after lipopolysaccharide injection, respectively, following the highest dose of the drug), reduced hypotension, ameliorated liver function, decreased plasma nitrite levels, restored the hyporeactivity of aortic rings to their control values and inhibited the activity of inducible NO synthase in the liver and in the aorta. Finally, U-74389G in vitro (12.5, 25 and 50 mu M) significantly inhibited nitrite production in endotoxin stimulated peritoneal macrophages. The data suggest that U-74389G may exert beneficial effects in an experimental model of septic shock by inhibiting the activity of the inducible NO synthase. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 27 条
[1]   G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS [J].
ALTAVILLA, D ;
SQUADRITO, F ;
CANALE, P ;
IOCULANO, M ;
SQUADRITO, G ;
CAMPO, GM ;
SERRANO, M ;
SARDELLA, A ;
URNA, G ;
SPIGNOLI, G ;
CAPUTI, AP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 286 (01) :31-39
[2]  
Campo GM, 1996, J PHARMACOL EXP THER, V277, P333
[3]   NITRIC-OXIDE AND NITRIC OXIDE-GENERATING COMPOUNDS INHIBIT HEPATOCYTE PROTEIN-SYNTHESIS [J].
CURRAN, RD ;
FERRARI, FK ;
KISPERT, PH ;
STADLER, J ;
STUEHR, DJ ;
SIMMONS, RL ;
BILLIAR, TR .
FASEB JOURNAL, 1991, 5 (07) :2085-2092
[4]   MOLECULAR MECHANISMS OF NITRIC-OXIDE REGULATION - POTENTIAL RELEVANCE TO CARDIOVASCULAR-DISEASE [J].
DINERMAN, JL ;
LOWENSTEIN, CJ ;
SNYDER, SH .
CIRCULATION RESEARCH, 1993, 73 (02) :217-222
[5]  
DING AH, 1988, J IMMUNOL, V141, P2407
[6]   Use of selective and nonselective nitric oxide synthase inhibitors in rat endotoxemia: Effects on hepatic morphology and function [J].
Gundersen, Y ;
Corso, CO ;
Leiderer, R ;
Dorger, M ;
Lilleaasen, P ;
Aasen, AO ;
Messmer, K .
SHOCK, 1997, 8 (05) :368-372
[7]   ROLE OF NITRIC-OXIDE IN MAINTAINING VASCULAR INTEGRITY IN ENDOTOXIN-INDUCED ACUTE INTESTINAL DAMAGE IN THE RAT [J].
HUTCHESON, IR ;
WHITTLE, BJR ;
BOUGHTONSMITH, NK .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (04) :815-820
[8]  
KUNIMOTO F, 1987, CIRC SHOCK, V21, P15
[9]  
McCall J M, 1987, Acta Anaesthesiol Belg, V38, P417
[10]  
MORGAN RA, 1987, CIRC SHOCK, V25, P319